Haibo B. Zhu

No.119, South Fourth Ring West Road
Fengtai, 100070, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Pituitary adenomas associated with hydrocephalus: clinical characteristics, risk stratification, and clinical management.

Pituitary adenomas associated with hydrocephalus: clinical characteristics, risk stratification, and clinical management.

Journal: Journal of neuro-oncology

Published: April 29, 2026

Calcified pituitary adenomas: First comprehensive characterization of a distinct clinical entity driven by GNAQ-mediated calcium-mitochondrial axis.

Calcified pituitary adenomas: First comprehensive characterization of a distinct clinical entity driven by GNAQ-mediated calcium-mitochondrial axis.

Journal: Experimental neurology

Published: February 17, 2026

Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies.

Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies.

Journal: Frontiers in immunology

Published: September 30, 2025

Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia.

Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia.

Journal: Journal of hematology & oncology

Published: September 02, 2025

Metagenomics next-generation sequencing of plasma combined with blood cells for improving the prognosis of early infection in patients with hematologic disorders: a real-world cohort study in northern China.

Metagenomics next-generation sequencing of plasma combined with blood cells for improving the prognosis of early infection in patients with hematologic disorders: a real-world cohort study in northern China.

Journal: Frontiers in molecular biosciences

Published: July 29, 2025

Case Report: CD19 CAR-T therapy induces dual remission in AML-M2b patient with CNS-PTLD and relapse.

Case Report: CD19 CAR-T therapy induces dual remission in AML-M2b patient with CNS-PTLD and relapse.

Journal: Frontiers in immunology

Published: July 24, 2025

Endoscopic endonasal approach for craniopharyngioma resection in 604 cases: tumor classification, treatment strategies, and surgical outcomes.

Endoscopic endonasal approach for craniopharyngioma resection in 604 cases: tumor classification, treatment strategies, and surgical outcomes.

Journal: Journal of neurosurgery

Published: April 15, 2025

Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.

Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.

Journal: Frontiers in immunology

Published: November 19, 2024

Single-cell transcriptomics identify a novel macrophage population associated with bone invasion in pituitary neuroendocrine tumors.

Single-cell transcriptomics identify a novel macrophage population associated with bone invasion in pituitary neuroendocrine tumors.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 13, 2024

Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemia.

Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemia.

Journal: Chinese medical journal

Published: May 07, 2024

TNF-α can promote membrane invasion by activating the MAPK/MMP9 signaling pathway through autocrine in bone-invasive pituitary adenoma.

TNF-α can promote membrane invasion by activating the MAPK/MMP9 signaling pathway through autocrine in bone-invasive pituitary adenoma.

Journal: CNS neuroscience & therapeutics

Published: February 05, 2024

Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy.

Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy.

Journal: International immunopharmacology

Published: January 08, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026